Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | huntingtin | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | hypothetical protein | Get druggable targets OG5_132837 | All targets in OG5_132837 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Onchocerca volvulus | Huntingtin homolog | Get druggable targets OG5_132837 | All targets in OG5_132837 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Onchocerca volvulus | Huntingtin homolog | Get druggable targets OG5_132837 | All targets in OG5_132837 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132837 | All targets in OG5_132837 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132837 | All targets in OG5_132837 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0184 | 0.0425 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.004 | 0.004 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0184 | 0.0425 | 0.5 |
Brugia malayi | hypothetical protein | 0.0184 | 0.0425 | 0.0425 |
Brugia malayi | Carboxylesterase family protein | 0.1092 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.0425 | 0.0425 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.0425 | 0.0425 |
Loa Loa (eye worm) | carboxylesterase | 0.0184 | 0.0425 | 0.0425 |
Echinococcus granulosus | acetylcholinesterase | 0.1092 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0184 | 0.0425 | 0.0425 |
Brugia malayi | Carboxylesterase family protein | 0.0184 | 0.0425 | 0.0425 |
Loa Loa (eye worm) | carboxylesterase | 0.0184 | 0.0425 | 0.0425 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.0425 | 0.0425 |
Echinococcus multilocularis | acetylcholinesterase | 0.1092 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.0425 | 0.0425 |
Loa Loa (eye worm) | hypothetical protein | 0.1092 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.1092 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.1092 | 1 | 1 |
Echinococcus granulosus | carboxylesterase 5A | 0.1092 | 1 | 1 |
Echinococcus multilocularis | carboxylesterase 5A | 0.1092 | 1 | 1 |
Onchocerca volvulus | 0.0184 | 0.0425 | 1 | |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0184 | 0.0425 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.0425 | 0.0425 |
Brugia malayi | Carboxylesterase family protein | 0.0184 | 0.0425 | 0.0425 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0184 | 0.0425 | 0.5 |
Echinococcus granulosus | acetylcholinesterase | 0.1092 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.1092 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.0425 | 0.0425 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0184 | 0.0425 | 0.5 |
Onchocerca volvulus | 0.0184 | 0.0425 | 1 | |
Loa Loa (eye worm) | carboxylesterase | 0.1092 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.004 | 0.004 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0184 | 0.0425 | 0.5 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0184 | 0.0425 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.0425 | 0.0425 |
Loa Loa (eye worm) | hypothetical protein | 0.1092 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0148 | 0.004 | 0.004 |
Onchocerca volvulus | 0.0184 | 0.0425 | 1 | |
Brugia malayi | Carboxylesterase family protein | 0.0184 | 0.0425 | 0.0425 |
Onchocerca volvulus | 0.0184 | 0.0425 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0891 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 21.1923 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 79.4328 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.